ArticleExperimental cell research2011

A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin.

Curtis R Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.